Sign up to save your podcasts
Or
Share E70-Archway 3 Port Delivery System for wAMD- Dr. Carl Regillo
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
E70-Archway 3 Port Delivery System for wAMD- Dr. Carl Regillo
Dr. Regillo describes the results of the phase 3 prospective study of Ranibizumab Port Delivery System (PDS) for the treatment of neovascular AMD.
Reference Article:
Regillo C, Berger B, Brooks L, Clark WL, Mittra R, Wykoff CC, Callaway NF, DeGraaf S, Ding HT, Fung AE, Gune S, Le Pogam S, Smith R, Willis JR, Barteselli G. Archway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year Results. Ophthalmology. 2023 Jul;130(7):735-747. doi: 10.1016/j.ophtha.2023.02.024. Epub 2023 Mar 2. PMID: 36870451.
View all episodes
By Keyvan Koushan, MD, FRCSC
4.4
1111 ratings
Dr. Regillo describes the results of the phase 3 prospective study of Ranibizumab Port Delivery System (PDS) for the treatment of neovascular AMD.
Reference Article:
Regillo C, Berger B, Brooks L, Clark WL, Mittra R, Wykoff CC, Callaway NF, DeGraaf S, Ding HT, Fung AE, Gune S, Le Pogam S, Smith R, Willis JR, Barteselli G. Archway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year Results. Ophthalmology. 2023 Jul;130(7):735-747. doi: 10.1016/j.ophtha.2023.02.024. Epub 2023 Mar 2. PMID: 36870451.
More shows like The Retina Channel Podcast
View all
Planet Money
30,795 Listeners
New Retina Radio by Eyetube
18 Listeners
Straight From The Cutter's Mouth: A Retina Podcast
97 Listeners
White Coat Investor Podcast
2,441 Listeners
The Daily
112,401 Listeners
Up First from NPR
56,702 Listeners
ESCRS Podcasts
2 Listeners
MedEdTalks - Ophthalmology
4 Listeners
Retina Synthesis
8 Listeners
Pupil Pod
10 Listeners
Experts InSight
50 Listeners
RETINA Journal Podcasts
11 Listeners
Knock Knock, Hi! with the Glaucomfleckens
465 Listeners
Ophthalmology Journal
19 Listeners
Talking Euretina
1 Listeners